Skip to content

On-line Cognitive Training for Parkinson's Disease

On-line Cognitive Training for Mild Cognitive Impairment in Parkinson's Disease: a Randomized Single-blind Study Using Wearing Sensors Technology

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04259827
Enrollment
60
Registered
2020-02-07
Start date
2019-10-15
Completion date
2021-02-10
Last updated
2020-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Application of online cognitive training in patients affected by Parkinson's disease and mild cognitive impairment. The treatment consists of a 6-week on-line cognitive training preceded and followed by neurological, neuropsychological and motor assessment.

Detailed description

At the recruitment, participants will undergo a neurological visit, a neuropsychology assessment (2 tests for each considered cognitive domain: memory, attention, visuospatial, executive function, language) and a motor assessment with wearing sensors under supervised conditions. In the treatment arm only, patients will have the Neuronation application installed on their personal technology device (smartphone or tablet) and are asked to complete 4 training session three times a week. Each session is composed of 5 exercises from one out of 4 cognitive domains: Memory, Attention, Speed and Reasoning. The training is tailor made, the complexity of the exercises is adjusted online, based on the patient's performance. Participants are re-assessed at the end of the 6-week cognitive training (T1) to find out its effects on cognition and motor ability. The same assessment is administered also after 1 (T2) and 3 (T3) months from the end of the cognitive training to test long-term effects.

Interventions

OTHERNeuronation

Online cognitive training app, with exercises created for patients with mild cognitive impairment

OTHERAspecific online games

Online gaming without cognitive training

Sponsors

Università degli Studi di Brescia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

The cognitive, motor and wearing sensors assessment will be performed by investigators blind to the treatment performed

Intervention model description

The study is a 3-arms single-blind parallel study. The patients are not blind to treatment , the investigators who will perform the baseline and follow-up assessment will be blinded to the treatment performed.

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Ease of use of at home internet connection * Active presence of a caregiver to help with the use of the App * Sufficient physical ability to use a technological device * Signature of informed consent

Exclusion criteria

* Presence of systemic pathologies potentially responsible for cognitive deficits * Presence of pathologies of the Central Nervous system potentially associated with cognitive deficits * No access to internet connection * Cognitive rehabilitation within the previous 6 months * Major depression (assessed by Beck Depression Inventory at baseline)

Design outcomes

Primary

MeasureTime frameDescription
Quality of life - caregiversChanges between baseline, immediately after the end of intervention, after 1 month and 3 monthsCaregiver Burden will be assessed with Dyadic relationship scale
Trial making B performance, total score (0-240 seconds)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthsTrial making B performance, total score (0-240 seconds)
Sum of total Z-score of cognitive assessment (-30 to 30)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthsSum of total Z-score of cognitive assessment (-30 to 30)
Supervised gait performance normal gaitChanges between baseline, immediately after the end of intervention, after 1 month and 3 monthsStep variability using wearing sensors technology in one-minute supervised walking
Supervised gait performance dual task gaitChanges between baseline, immediately after the end of intervention, after 1 month and 3 monthsStep variability using wearing sensors technology in one-minute supervised dual task walking
Parkinson´s disease Quality of life questionnire (PDQ-39) (0-117 points)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthsPDQ-39 will be assessed in patients

Secondary

MeasureTime frameDescription
Instability measuresChanges between baseline, immediately after the end of intervention, after 1 month and 3 monthsWearing sensors-based instability assessment (area of sway)
Turning performancesChanges between baseline, immediately after the end of intervention, after 1 month and 3 monthsWearing sensors based turning speed in timed up and go test
Dual task performance in circular walking (0-240 seconds)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthsTime performed in dual-task circular walking
Short Physical performance battery (SPPB), total time (0- 60 seconds)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthsShort Physical performance battery
Unified parkinson´s disease Rating Scale part 3 (0-132 points)Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthssTotal Movement Disorder Society-Unified Parkinson's disease Rating Scale part 3 motor score

Countries

Italy

Contacts

Primary ContactAndrea Pilotto, MD
andrea.pilotto@unibs.it00393396245281
Backup ContactSara Nocivelli, Psy
sara.nocivelli@unibs.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026